Brian E Conway
Biographic Data
| ID | 5413400 |
|---|---|
| NAME | Brian E Conway |
| GIVEN NAMES | Brian E |
| FAMILY NAME | Conway |
| SIGNATURE | CONWAY B E |
| AFFILIATIONS | Vancouver Infectious Diseases Centre |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use
The relatively high incidence of reinfection seen in this study underscores the importance of targeted harm reduction measures and monitoring for HCV reinfections within the first year following successful treatment among people who inject drugs. Additional research into integrated models of care incorporating harm reduction and supporting reducing risk of reinfection and HCV treatment are needed
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Is There a Need for Heroin Substitution Treatment in Vancouver’s Downtown Eastside
Is There a Need for Heroin Substitution Treatment in Vancouver’s Downtown Eastside
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use
The relatively high incidence of reinfection seen in this study underscores the importance of targeted harm reduction measures and monitoring for HCV reinfections within the first year following successful treatment among people who inject drugs. Additional research into integrated models of care incorporating harm reduction and supporting reducing risk of reinfection and HCV treatment are needed
Medicine (3 works) · Drug (2 works) · Hepatitis C (2 works) · Hepatitis C virus (2 works) · Hepatitis C virus research (2 works) · HIV, Drug Use, Sexual Risk (2 works) · Internal Medicine (2 works) · Virology (2 works) · Virus (2 works) · Antiviral therapy (1 work)